
GC Biopharma secures largest share of Korea's national flu vaccine bid
GC Biopharma said it has won the largest share in the Korea Disease Control and Prevention Agency’s (KDCA) national procurement bid for the 2025–2026 seasonal influenza vaccine. The company will supply 2.63 million doses, the highest volume awarded in the …